Director/PDMR Shareholding

RNS Number : 8755N

AstraZeneca PLC

25 February 2009

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

We hereby inform you that on 24 February 2009, the interest of the following Directors in AstraZeneca PLC Ordinary Shares of $0.25 each changed as detailed below. The change in interest relates to the vesting of previously announced awards made in February 2006 under the AstraZeneca Deferred Bonus Plan whereby the individuals concerned have now become beneficially entitled to the shares. In each case, sufficient shares were withheld to cover certain tax obligations arising on the vesting.

Name of Director	Number of Shares Vested	Number of Shares Withheld	Net Number of Shares	Current Holding	Percentage of Issued Share Capital
David R Brennan	6,352	2,605	3,747	See below	See below
John Patterson	6,623	2,716	3,907	152,446	0.01%

Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share.

As a result of this transaction, Mr Brennan's interest is now 393,369 Ordinary Shares and 116,689 AstraZeneca ADSs, which together represent approximately 0.035% of the Company's issued ordinary capital.

The closing market price of AstraZeneca PLC Ordinary Shares of $0.25 each on 24 February 2009 was 2415 pence.

A C N Kemp

Company Secretary

25 February 2009

 

END

 

 

RDSUVOSRKARUUAR